Suppliers in Broomall, PA
8 Medicare Suppliers found. Showing 1 - 8
 Health Care Solutions Medicare Supplier Location: 500 Abbott Dr, Broomall, Pennsylvania 19008 Phone: (610) 544-6023 |
Cvs Pharmacy #02756 Durable Medical Equipment & Medical Supplies Location: 2507 W Chester Pike, Broomall, Pennsylvania 19008 Phone: (610) 325-5301 |
Cvs Pharmacy #05462 Durable Medical Equipment & Medical Supplies Location: 1991 Sproul Rd, Broomall, Pennsylvania 19008 Phone: (610) 325-8422 |
Rite Aid Pharmacy 01567 Durable Medical Equipment & Medical Supplies Location: 2901 Springfield Rd, Broomall, Pennsylvania 19008 Phone: (610) 356-8800 |
Sav-on Pharmacy #3798 Durable Medical Equipment & Medical Supplies Location: 567 Sproul Rd, Broomall, Pennsylvania 19008 Phone: (610) 356-3504 |
Giant Pharmacy #6523 Pharmacy Location: 2180 W Chester Pike, Broomall, Pennsylvania 19008 Phone: (610) 355-9244 |
Break-n-brace Durable Medical Equipment & Medical Supplies Location: 2004 Sproul Rd, Broomall, Pennsylvania 19008 Phone: (610) 356-3730 |
Broomall Medicare Supplier Location: Lawrence Park Business Center, Broomall, Pennsylvania 19008 Phone: (215) 496-1307 |
News Archive
Past exposure to pathogens leads to disease resistance spreading through populations
A study by researchers at Royal Holloway, University of London, University College London and Oxford University, has found that a genetic variant which reduces the chance of contracting diseases such as tuberculosis and leprosy is more prevalent in populations with long histories of urban living.
New platform prioritizes synergistic drug combinations against SARS-CoV-2
Researchers in the U.S. have used a new web-based platform to help identify synergistic and antagonistic drug combinations and their underlying mechanisms of action in the context of coronavirus disease 2019 (COVID-19).
Bristol-Myers Squibb declares quarterly dividend
The Board of Directors of Bristol-Myers Squibb Company today declared a quarterly dividend of 32 cents ($0.32) per share on the $0.10 par value Common Stock of the corporation. The quarterly dividend will be payable on August 2, 2010 to stockholders of record at the close of business on July 2, 2010.
New data reveals the efficacy of Instanyl in management of breakthrough cancer pain
New data presented today further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain. The data which were presented at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC) are from a multinational, crossover trial comparing Instanyl with oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in patients with cancer.
› Verified 3 days ago